1.30 USD
▼0.00-2.26%
2026-08-03
市值
$63.99M
市盈率
—
EPS
-0.24
股息率
—
52 周区间
1.17 – 1.96
成交量
82.92K
Beta
0.62
目标价
9.00
52W 低 1.1752W 高 1.96
价格走势
公司简介
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute res...